Cargando…

A re-appraisal of mesenchymal-epithelial transition (MET) in endometrial epithelial remodeling

Mesenchymal-epithelial transition (MET) is a mechanism of endometrial epithelial regeneration. It is also implicated in adenocarcinoma and endometriosis. Little is known about this process in normal uterine physiology. Previously, using pregnancy and menses-like mouse models, MET occurred only as an...

Descripción completa

Detalles Bibliográficos
Autores principales: Spooner-Harris, Madelyn, Kerns, Karl, Zigo, Michal, Sutovsky, Peter, Balboula, Ahmed, Patterson, Amanda L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9889438/
https://www.ncbi.nlm.nih.gov/pubmed/36401092
http://dx.doi.org/10.1007/s00441-022-03711-z
_version_ 1784880730167312384
author Spooner-Harris, Madelyn
Kerns, Karl
Zigo, Michal
Sutovsky, Peter
Balboula, Ahmed
Patterson, Amanda L.
author_facet Spooner-Harris, Madelyn
Kerns, Karl
Zigo, Michal
Sutovsky, Peter
Balboula, Ahmed
Patterson, Amanda L.
author_sort Spooner-Harris, Madelyn
collection PubMed
description Mesenchymal-epithelial transition (MET) is a mechanism of endometrial epithelial regeneration. It is also implicated in adenocarcinoma and endometriosis. Little is known about this process in normal uterine physiology. Previously, using pregnancy and menses-like mouse models, MET occurred only as an epithelial damage/repair mechanism. Here, we hypothesized that MET also occurs in other physiological endometrial remodeling events, outside of damage/repair, such as during the estrous cycle and adenogenesis (gland development). To investigate this, Amhr2-Cre-YFP/GFP mesenchyme-specific reporter mice were used to track the fate of mesenchymal-derived (MD) cells. Using EpCAM (epithelial marker), EpCAM(+)YFP(+) MD-epithelial cells were identified in all stages of the estrous cycle except diestrus, in both postpartum and virgin mice. EpCAM(+)YFP(+) MD-epithelial cells comprised up to 80% of the epithelia during estrogen-dominant proestrus and significantly declined to indistinguishable from control uteri in diestrus, suggesting MET is hormonally regulated. MD-epithelial cells were also identified during postnatal epithelial remodeling. MET occurred immediately after birth at postnatal day (P) 0.5 with EpCAM(+)GFP(+) cells ranging from negligible (0.21%) to 82% of the epithelia. EpCAM(+)GFP(+) MD-epithelial cells declined during initiation of adenogenesis (P8, avg. 1.75%) and then increased during gland morphogenesis (P14, avg. 10%). MD-epithelial cells expressed markers in common with non-MD-epithelial cells (e.g., EpCAM, FOXA2, ESR1, PGR). However, MD-epithelial cells were differentially regulated postnatally and in adults, suggesting a functional distinction in the two populations. We conclude that MET occurs not only as an epithelial damage/repair mechanism but also during other epithelial remodeling events, which to our knowledge has not been demonstrated in other tissues. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00441-022-03711-z.
format Online
Article
Text
id pubmed-9889438
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-98894382023-02-02 A re-appraisal of mesenchymal-epithelial transition (MET) in endometrial epithelial remodeling Spooner-Harris, Madelyn Kerns, Karl Zigo, Michal Sutovsky, Peter Balboula, Ahmed Patterson, Amanda L. Cell Tissue Res Regular Article Mesenchymal-epithelial transition (MET) is a mechanism of endometrial epithelial regeneration. It is also implicated in adenocarcinoma and endometriosis. Little is known about this process in normal uterine physiology. Previously, using pregnancy and menses-like mouse models, MET occurred only as an epithelial damage/repair mechanism. Here, we hypothesized that MET also occurs in other physiological endometrial remodeling events, outside of damage/repair, such as during the estrous cycle and adenogenesis (gland development). To investigate this, Amhr2-Cre-YFP/GFP mesenchyme-specific reporter mice were used to track the fate of mesenchymal-derived (MD) cells. Using EpCAM (epithelial marker), EpCAM(+)YFP(+) MD-epithelial cells were identified in all stages of the estrous cycle except diestrus, in both postpartum and virgin mice. EpCAM(+)YFP(+) MD-epithelial cells comprised up to 80% of the epithelia during estrogen-dominant proestrus and significantly declined to indistinguishable from control uteri in diestrus, suggesting MET is hormonally regulated. MD-epithelial cells were also identified during postnatal epithelial remodeling. MET occurred immediately after birth at postnatal day (P) 0.5 with EpCAM(+)GFP(+) cells ranging from negligible (0.21%) to 82% of the epithelia. EpCAM(+)GFP(+) MD-epithelial cells declined during initiation of adenogenesis (P8, avg. 1.75%) and then increased during gland morphogenesis (P14, avg. 10%). MD-epithelial cells expressed markers in common with non-MD-epithelial cells (e.g., EpCAM, FOXA2, ESR1, PGR). However, MD-epithelial cells were differentially regulated postnatally and in adults, suggesting a functional distinction in the two populations. We conclude that MET occurs not only as an epithelial damage/repair mechanism but also during other epithelial remodeling events, which to our knowledge has not been demonstrated in other tissues. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00441-022-03711-z. Springer Berlin Heidelberg 2022-11-19 2023 /pmc/articles/PMC9889438/ /pubmed/36401092 http://dx.doi.org/10.1007/s00441-022-03711-z Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Regular Article
Spooner-Harris, Madelyn
Kerns, Karl
Zigo, Michal
Sutovsky, Peter
Balboula, Ahmed
Patterson, Amanda L.
A re-appraisal of mesenchymal-epithelial transition (MET) in endometrial epithelial remodeling
title A re-appraisal of mesenchymal-epithelial transition (MET) in endometrial epithelial remodeling
title_full A re-appraisal of mesenchymal-epithelial transition (MET) in endometrial epithelial remodeling
title_fullStr A re-appraisal of mesenchymal-epithelial transition (MET) in endometrial epithelial remodeling
title_full_unstemmed A re-appraisal of mesenchymal-epithelial transition (MET) in endometrial epithelial remodeling
title_short A re-appraisal of mesenchymal-epithelial transition (MET) in endometrial epithelial remodeling
title_sort re-appraisal of mesenchymal-epithelial transition (met) in endometrial epithelial remodeling
topic Regular Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9889438/
https://www.ncbi.nlm.nih.gov/pubmed/36401092
http://dx.doi.org/10.1007/s00441-022-03711-z
work_keys_str_mv AT spoonerharrismadelyn areappraisalofmesenchymalepithelialtransitionmetinendometrialepithelialremodeling
AT kernskarl areappraisalofmesenchymalepithelialtransitionmetinendometrialepithelialremodeling
AT zigomichal areappraisalofmesenchymalepithelialtransitionmetinendometrialepithelialremodeling
AT sutovskypeter areappraisalofmesenchymalepithelialtransitionmetinendometrialepithelialremodeling
AT balboulaahmed areappraisalofmesenchymalepithelialtransitionmetinendometrialepithelialremodeling
AT pattersonamandal areappraisalofmesenchymalepithelialtransitionmetinendometrialepithelialremodeling
AT spoonerharrismadelyn reappraisalofmesenchymalepithelialtransitionmetinendometrialepithelialremodeling
AT kernskarl reappraisalofmesenchymalepithelialtransitionmetinendometrialepithelialremodeling
AT zigomichal reappraisalofmesenchymalepithelialtransitionmetinendometrialepithelialremodeling
AT sutovskypeter reappraisalofmesenchymalepithelialtransitionmetinendometrialepithelialremodeling
AT balboulaahmed reappraisalofmesenchymalepithelialtransitionmetinendometrialepithelialremodeling
AT pattersonamandal reappraisalofmesenchymalepithelialtransitionmetinendometrialepithelialremodeling